Genetic biomarkers of placebo response: what could it mean for future trial design?

Clin Investig (Lond). 2013 Apr 1;3(4):311-314. doi: 10.4155/cli.13.8.

Authors

Kathryn T Hall¹, Ted J Kaptchuk

Affiliation

¹ Program in Placebo Studies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA ; Division of General Medicine & Primary Care, Beth Israel Deaconess Medical Center, Boston, MA, USA.

No abstract available

Keywords: COMT; Val158Met; biomarkers; doctor–patient; enrichment strategies; placebo effect; randomized controlled trial.

Grants and funding